- Home
- A-Z Publications
- Current Drug Metabolism
- Previous Issues
- Volume 18, Issue 5, 2017
Current Drug Metabolism - Volume 18, Issue 5, 2017
Volume 18, Issue 5, 2017
-
-
Dermatokinetics as an Important Tool to Assess the Bioavailability of Drugs by Topical Nanocarriers
Authors: Nagarani Thotakura, Pramod Kumar, Sheetu Wadhwa, Kaisar Raza and Prakash KatareBackground: Now-a-days, numerous nanocarrier-based drug products for topical applications are present in the market and number of similar products are being researched. To estimate the amount of drug delivery to skin, the scientists have now established techniques for separation of skin layers for the determination of drug concentrations. This forms the basis of pharmacokinetics of drug(s) in skin, i.e., dermatokinetic Read More
-
-
-
Nanosystems for Skin Delivery: From Drugs to Cosmetics
Authors: Ana F. Antunes, Paula Pereira, Claudia Reis, Patrícia Rijo and Catarina ReisBackground: Skin delivery is an exciting and challenging area. There are numerous skin delivery systems available on the market. However, this market still remains limited to a narrow range of substances. Thus, several strategies have been developed to improve the performance of those substances, including the development of nanosystems. Methods: The aim of this review is to elucidate the nanosystems applied to the s Read More
-
-
-
Challenges in Dermal Delivery of Therapeutic Antimicrobial Protein and Peptides
Authors: Rohan Lalani, Ambikanandan Misra, Jitendra Amrutiya, Hinal Patel, Priyanka Bhatt and Vivek PatelBackground: Protein and peptides in biological system form an important part of innate immune system and are being explored for potential use in various diseases as therapeutics. Importance of proteins and peptides as a new class of antimicrobial agents has boosted research in the field of biotechnology as potential alternative to antibiotic agents. Objective: Protein and peptides antimicrobial as a therapeutic class are struct Read More
-
-
-
Antioxidant Nanoplatforms for Dermal Delivery: Melatonin
More LessBackground: Melatonin is emerging as a promising therapeutic agent, mainly due to its role as antioxidant. Substantial evidences show that melatonin is potentially effective in a variety of diseases as cancer, inflammation and neurodegenerative diseases. The excellent antioxidant capacity with pharmacokinetics characteristics and the emerging search for new pharmaceutical nanotechnology based systems, make Read More
-
-
-
Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment
Authors: Sevgi Gungor and Meriem RezigueBackground: Psoriasis is a chronic autoimmune inflammatory skin disease affecting 2 to 3% of people worldwide. Topical therapy as first option in the management of psoriasis is an attractive strategy by delivering drugs efficiently into target sites of disease, minimizing systemic side effects of drugs and ensuring high patient compliance. However, the delivery of antipsoriatic agents via conventional topical formulations is limite Read More
-
-
-
Lipid-Based Nanoparticles as Carriers for Dermal Delivery of Antioxidants
More LessBackground: The skin, being the outermost layer of our body, is constantly exposed to oxidative stress induced by UV-radiation, pollutants, smoke and xenobiotics. To counteract the deleterious effects of such exposure, the skin is equipped with a complex anti-oxidation system, involving both exogenous and endogenous antioxidants. As low molecular weight antioxidants undergo depletion in counteracting oxidative stress occu Read More
-
-
-
Transdermal Drug Delivery: Opportunities and Challenges for Controlled Delivery of Therapeutic Agents Using Nanocarriers
Authors: Balak Das Kurmi, Pawan Tekchandani, Rishi Paliwal and Shivani Rai PaliwalBackground: Transdermal drug delivery represents an extremely attractive and innovative route across the skin owing to the possibility for achieving systemic effect of drugs. The present scenario demands a special focus on developing safe medicine with minimized toxic adverse effects related to most of the pharmacologically active agents. Transdermal drug delivery would be a focal paradigm which provides patient co Read More
-
Volumes & issues
-
Volume 25 (2024)
-
Volume 24 (2023)
-
Volume 23 (2022)
-
Volume 22 (2021)
-
Volume 21 (2020)
-
Volume 20 (2019)
-
Volume 19 (2018)
-
Volume 18 (2017)
-
Volume 17 (2016)
-
Volume 16 (2015)
-
Volume 15 (2014)
-
Volume 14 (2013)
-
Volume 13 (2012)
-
Volume 12 (2011)
-
Volume 11 (2010)
-
Volume 10 (2009)
-
Volume 9 (2008)
-
Volume 8 (2007)
-
Volume 7 (2006)
-
Volume 6 (2005)
-
Volume 5 (2004)
-
Volume 4 (2003)
-
Volume 3 (2002)
-
Volume 2 (2001)
-
Volume 1 (2000)
Most Read This Month
Article
content/journals/cdm
Journal
10
5
false
en
